Explore additional resources describing the challenges of therapeutic delivery and TriNav® as a solution.
Case Presentations on Cancer Treatment Using TriNav Infusion System
Imaging Library for Cancer Treatment Using TriNav Infusion System
Y90 Mapping Procedure using TriNav® in Patient with Metastatic Neuroendocrine Tumor
Response to Microsphere Embolization Using the TriNav® Infusion System in Hypovascular Leiomyosarcoma Metastases
Super-Selective DEB-TACE Performed Using TriNav® in Patient with Hepatocellular Carcinoma
Clinical Summaries for Cancer Treatment Using PEDD Approach
Multi-Center Registry Study of the Safety, Feasibility, and Outcomes of Pressure-Enabled Drug Delivery in DEB-TACE for Patients with HCC
Pressure Enabled Drug Delivery™ — Clinical Evidence. Resonance of multiple clinical studies with different therapeutics
The Impact of Pressure-Enabled Drug Delivery™ on Target Volume Particulate Distribution in Liver-Directed Embolotherapy
Podcasts Related to Cancer Treatment
Bridging to Transplant with Dr. Jen Berumen and Dr. Isabel Newton
Episode 64Listen now
Locoregional Therapies for HCC with Dr. Alex Kim
Episode 67Listen now
Targeting the Tumor Microenvironment with Dr. Terence Gade
Episode 76Listen now
IO in Private Practice Part I with Dr. Justin Lee
Episode 91Listen now
IO in Private Practice Part 2 with Dr. Justin Lee
Episode 92Listen now
Cardiovascular and Interventional Radiology
End-hole Versus Microvalve Infusion Catheters in Patients Undergoing Drug-Eluting Microspheres-TACE for Solitary Hepatocellular Carcinoma Tumors: A Retrospective Analysis
Titano et al.
Journal of Vascular and Interventional Radiology
Abstract No. 133 Surefire Infusion System (SIS) hepatocellular carcinoma registry study interim results: a multicenter study of the safety, feasibility, and outcomes of the SIS expandable-tip microcatheter in DEB-TACE
Kapoor et al.
Using the TriNav Infusion System
Let us tell you more.
Contact us to learn more about this improved technology for the proprietary PEDD method.
Rx Only. For the safe and proper use of the TriNav device, refer to the Instructions for Use.
Indications for Use: The TriNav Infusion System is intended for use in angiographic procedures. It delivers radiopaque media and therapeutic agents to selected sites in the peripheral vascular system.1
Contraindications: TriNav is not intended for use in the vasculature of the central nervous system (including the neurovasculature) or central circulatory system (including the coronary vasculature).1
1. TriSalus™ TriNav® Infusion System, Instructions for Use.